Clinical Trial Update: Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of Progression [Phase 3]

View source ↗

Summary

Phase 3 pilot study results for ACTH in progressive IgA nephropathy with high risk of progression have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy
• Proteinuria

Drugs mentioned

• ACTH (adrenocorticotropic hormone)

Snippet

Sponsor: Mayo Clinic | Conditions: Progressive IgA Nephropathy, Proteinuria | Phase 3 | Status: COMPLETED | Results posted: 2019-06-26